Are selective estrogen receptor modulators (SERMs) a therapeutic option for HPV-associated cervical lesions and cancers?
- PMID: 24345353
- DOI: 10.1016/j.ajpath.2013.11.005
Are selective estrogen receptor modulators (SERMs) a therapeutic option for HPV-associated cervical lesions and cancers?
Abstract
This Commentary highlights the article by Spurgeon et al which evaluates oral SERM raloxifene as a potential therapeutic agent for HPV-associated cancer.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Comment on
-
Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy.Am J Pathol. 2014 Feb;184(2):530-40. doi: 10.1016/j.ajpath.2013.10.013. Am J Pathol. 2014. PMID: 24418098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical